NDC 21695-160

PAXIL CR

Paroxetine Hydrochloride

PAXIL CR is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Rebel Distributors Corp. The primary component is Paroxetine Hydrochloride.

Product ID21695-160_a73cf8ee-f99b-4972-8939-0d394a527134
NDC21695-160
Product TypeHuman Prescription Drug
Proprietary NamePAXIL CR
Generic NameParoxetine Hydrochloride
Dosage FormTablet, Film Coated, Extended Release
Route of AdministrationORAL
Marketing Start Date2002-04-09
Marketing CategoryNDA / NDA
Application NumberNDA020936
Labeler NameRebel Distributors Corp
Substance NamePAROXETINE HYDROCHLORIDE
Active Ingredient Strength25 mg/1
Pharm ClassesSerotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 21695-160-30

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (21695-160-30)
Marketing Start Date2002-04-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 21695-160-30 [21695016030]

PAXIL CR TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA020936
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2002-04-09
Inactivation Date2019-09-24

Drug Details

Active Ingredients

IngredientStrength
PAROXETINE HYDROCHLORIDE25 mg/1

Pharmacological Class

  • Serotonin Reuptake Inhibitor [EPC]
  • Serotonin Uptake Inhibitors [MoA]

NDC Crossover Matching brand name "PAXIL CR" or generic name "Paroxetine Hydrochloride"

NDCBrand NameGeneric Name
71335-0572PAXIL CRPAXIL CR
60505-3669PAXIL CRPAXIL CR
60505-3670PAXIL CRPAXIL CR
60505-3668PAXIL CRPAXIL CR
60505-4378PAXIL CRPAXIL CR
60505-4377PAXIL CRPAXIL CR
60505-4379PAXIL CRPAXIL CR
0904-5676PAROXETINEparoxetine hydrochloride
0904-5677PAROXETINEparoxetine hydrochloride
0904-5678PAROXETINEparoxetine hydrochloride
0904-5679PAROXETINEparoxetine hydrochloride
10544-433PAROXETINEparoxetine hydrochloride
10544-809PAROXETINEparoxetine hydrochloride
12634-248PAROXETINEparoxetine hydrochloride
16714-181ParoxetineParoxetine Hydrochloride
16714-182ParoxetineParoxetine Hydrochloride
16714-183ParoxetineParoxetine Hydrochloride
16714-184ParoxetineParoxetine Hydrochloride
21695-101ParoxetineParoxetine Hydrochloride
21695-102ParoxetineParoxetine Hydrochloride
21695-103ParoxetineParoxetine Hydrochloride
21695-104ParoxetineParoxetine Hydrochloride
43353-845ParoxetineParoxetine Hydrochloride
0378-2003Paroxetine Hydrochlorideparoxetine hydrochloride
0378-2004Paroxetine Hydrochlorideparoxetine hydrochloride
0378-2005Paroxetine Hydrochlorideparoxetine hydrochloride
21695-159PAXILparoxetine hydrochloride
21695-160PAXILparoxetine hydrochloride

Trademark Results [PAXIL]

Mark Image

Registration | Serial
Company
Trademark
Application Date
PAXIL
PAXIL
75284309 2220043 Live/Registered
GLAXOSMITHKLINE LLC
1997-04-30
PAXIL
PAXIL
75282874 2220037 Live/Registered
GLAXOSMITHKLINE LLC
1997-04-30
PAXIL
PAXIL
75180864 not registered Dead/Abandoned
SmithKline Beecham Corporation
1996-10-15
PAXIL
PAXIL
75180863 not registered Dead/Abandoned
SmithKline Beecham Corporation
1996-10-15
PAXIL
PAXIL
75169719 2219909 Live/Registered
GLAXOSMITHKLINE LLC
1996-09-20
PAXIL
PAXIL
75169698 2166898 Dead/Cancelled
SmithKline Beecham Corporation
1996-09-20
PAXIL
PAXIL
75169697 2219908 Live/Registered
GLAXOSMITHKLINE LLC
1996-09-20
PAXIL
PAXIL
75169675 2144154 Live/Registered
GLAXOSMITHKLINE LLC
1996-09-20
PAXIL
PAXIL
74184442 1821952 Live/Registered
GLAXOSMITHKLINE LLC
1991-07-12
PAXIL
PAXIL
73255881 1170889 Dead/Cancelled
Boehringer Ingelheim G.m.b.H.
1980-03-28
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.